MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
作者信息
Hocquet Didier, Roussel-Delvallez Micheline, Cavallo Jean-Didier, Plésiat Patrick
出版信息
Antimicrob Agents Chemother. 2007 Apr;51(4):1582-3. doi: 10.1128/AAC.01334-06. Epub 2007 Jan 12.
Abstract
摘要
相似文献
1
MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
Antimicrob Agents Chemother. 2007 Apr;51(4):1582-3. doi: 10.1128/AAC.01334-06. Epub 2007 Jan 12.
2
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008 Mar;52(3):1173-5. doi: 10.1128/AAC.01212-07. Epub 2008 Jan 7.
3
Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
J Antimicrob Chemother. 2012 Mar;67(3):771-5. doi: 10.1093/jac/dkr543. Epub 2012 Jan 3.
4
MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.
Mol Microbiol. 2004 Sep;53(5):1423-36. doi: 10.1111/j.1365-2958.2004.04210.x.
5
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
Int J Antimicrob Agents. 2009 Oct;34(4):343-6. doi: 10.1016/j.ijantimicag.2009.06.007. Epub 2009 Jul 16.
6
In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
Int J Antimicrob Agents. 2009 May;33(5):417-20. doi: 10.1016/j.ijantimicag.2008.10.029. Epub 2009 Jan 20.
7
Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
J Antimicrob Chemother. 2005 Apr;55(4):518-22. doi: 10.1093/jac/dki030. Epub 2005 Feb 18.
8
Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction.
FEMS Microbiol Lett. 2005 Feb 1;243(1):125-31. doi: 10.1016/j.femsle.2004.11.048.
9
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2006 Apr;50(4):1347-51. doi: 10.1128/AAC.50.4.1347-1351.2006.
10
Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.
引用本文的文献
1
Regulation, structure, and activity of the MexXY efflux system.
Antimicrob Agents Chemother. 2025 Apr 7;69(5):e0182524. doi: 10.1128/aac.01825-24.
2
New understanding of multidrug efflux and permeation in antibiotic resistance, persistence, and heteroresistance.
Ann N Y Acad Sci. 2023 Jan;1519(1):46-62. doi: 10.1111/nyas.14921. Epub 2022 Nov 7.
3
Effects of Verapamil and Two Bisbenzylisoquinolines, Curine and Guattegaumerine Extracted from on the Inhibition of ABC Transporters from .
Antibiotics (Basel). 2022 May 21;11(5):700. doi: 10.3390/antibiotics11050700.
4
Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria.
Antibiotics (Basel). 2021 Sep 16;10(9):1117. doi: 10.3390/antibiotics10091117.
5
Identification of the PA1113 Gene Product as an ABC Transporter Involved in the Uptake of Carbenicillin in PAO1.
Antibiotics (Basel). 2020 Sep 11;9(9):596. doi: 10.3390/antibiotics9090596.
6
Interaction of ArmZ with the DNA-binding domain of MexZ induces expression of multidrug efflux pump genes and antimicrobial resistance in .
Antimicrob Agents Chemother. 2019 Sep 9;63(12). doi: 10.1128/AAC.01199-19. Epub 2019 Sep 16.
7
Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01081-19. Print 2019 Oct.
8
MexXY Multidrug Efflux System Is More Frequently Overexpressed in Ciprofloxacin Resistant French Clinical Isolates Compared to Hospital Environment Ones.
Front Microbiol. 2019 Feb 26;10:366. doi: 10.3389/fmicb.2019.00366. eCollection 2019.
9
Multidrug-resistant from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.
Infect Drug Resist. 2018 Sep 17;11:1499-1510. doi: 10.2147/IDR.S173804. eCollection 2018.
10
Broad-spectrum resistance of Pseudomonas aeruginosa from shellfish: infrequent acquisition of novel resistance mechanisms.
Environ Monit Assess. 2018 Jan 15;190(2):81. doi: 10.1007/s10661-018-6471-3.
本文引用的文献
1
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.
Clin Microbiol Rev. 2006 Apr;19(2):382-402. doi: 10.1128/CMR.19.2.382-402.2006.
2
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2006 Apr;50(4):1347-51. doi: 10.1128/AAC.50.4.1347-1351.2006.
3
Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR.
FEMS Microbiol Lett. 2006 Jan;254(2):217-25. doi: 10.1111/j.1574-6968.2005.00008.x.
4
Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.
Antimicrob Agents Chemother. 2004 May;48(5):1797-802. doi: 10.1128/AAC.48.5.1797-1802.2004.
5
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
Antimicrob Agents Chemother. 2001 Jan;45(1):105-16. doi: 10.1128/AAC.45.1.105-116.2001.
6
Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.
Antimicrob Agents Chemother. 2000 Sep;44(9):2233-41. doi: 10.1128/AAC.44.9.2233-2241.2000.
Zotero 插件